Robert Forrester

Robert Forrester is a declared insider at 3 companies; the most frequent names are EPIRUS Biopharmaceuticals, Inc., Verastem, Inc. and CPEX Pharmaceuticals, Inc. The record holds 33 filings, for trades running from 26 January 2006 to 28 September 2018.

In open-market terms, that means 11 purchases worth €137k on one side and 10 sales worth €25k on the other. On balance, insiders were net buyers of €111k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 9 share grants and 2 option exercises. So far in 2018, the count stands at 3 purchases and no sales.

The median purchase comes to €7,723. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 8 purchases with a full 90-day history, the hit rate stands at 38% and the median 90-day move at -34.2%. These figures describe past trades and do not predict future prices.

On 2 October 2018 came the latest disclosure, an open-market purchase for €12k in Verastem, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.